Finance

Lists
A1LB34:BVMF
Albemarle Corp Bdr
R$21.08
0.00%
(0.00) 1D
Oct 29, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1LB34...
Open
R$21.52
High
R$21.52
Low
R$21.04
Mkt. cap
11.01B
Avg. vol.
2.31K
Volume
2.06K
52-wk high
R$44.96
52-wk low
R$19.20
Shares outstanding
118.01M
No. of employees
8K
Open
R$21.52
High
R$21.52
Low
R$21.04
Mkt. cap
11.01B
Avg. vol.
2.31K
Volume
2.06K
52-wk high
R$44.96
52-wk low
R$19.20
Shares outstanding
118.01M
No. of employees
8K
News stories
From web sources and news partners
Profile
Albemarle Corporation is an American specialty chemicals and mining company headquartered in Charlotte, North Carolina. Its principal businesses produce lithium compounds used in electric-vehicle batteries and energy-storage systems, and bromine-based specialty chemicals, including flame retardants. The company traces its origins to the Albemarle Paper Manufacturing Company, founded in Richmond, Virginia, in 1887. The present company became an independent publicly traded corporation in 1994, when Ethyl Corporation spun off its specialty-chemicals business. In 2025, Albemarle reported net sales of approximately US$5.1 billion and approximately 7,800 employees, including employees of its consolidated joint ventures. Albemarle is one of the world's largest lithium producers. It extracts lithium from brine at the Salar de Atacama in Chile and at Silver Peak, Nevada. In 2025, commercial-scale lithium production in the United States came from a single continental-brine operation in Nevada. The company also holds interests in the Greenbushes and Wodgina hard-rock spodumene mines in Western Australia and operates lithium-conversion facilities in several countries. Wikipedia
About Albemarle Corp Bdr
CEOJ Kent Masters
Employees7.8K
FoundedFeb 28, 1994
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.31B
1.43B
1.43B
1.74B
Cost of goods sold
1.19B
1.23B
927.76M
1.15B
Cost of revenue
1.19B
1.23B
927.76M
1.15B
Research and development expenses
12.67M
12.18M
9.17M
3.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133.78M
158.24M
137.67M
107.46M
Operating expense
146.46M
170.42M
146.84M
111.13M
Total operating expenses
1.34B
1.40B
1.07B
1.26B
Operating income
-28.84M
32.31M
354.13M
483.07M
Other non operating income
39.88M
179.27M
76.45M
14.50M
EBT including unusual items
-178.51M
-244.43M
350.49M
593.21M
EBT excluding unusual items
1.54M
37.70M
465.38M
613.78M
Income tax expense
-30.56M
157.33M
21.51M
94.00M
Effective tax rate
17.12%
-64.37%
6.14%
15.85%
Other operating expenses
-
-
-
-
Net income
-160.69M
-414.18M
319.09M
479.96M
Net profit margin
-12.29%
-29.00%
22.33%
27.53%
Earnings per share
-0.19
-0.53
2.95
3.75
Interest and investment income
-
-
-
-
Interest expense
-50.96M
-50.30M
-45.71M
-30.92M
Net interest expenses
-50.96M
-50.30M
-45.71M
-30.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
135.64M
196.02M
511.94M
638.87M
Gain or loss from assets sale
-
-
95.02M
-
Upcoming events
AI content may include mistakes. Learn more
Google apps